Danish RAndomized Trial of External Ventricular Drainage Cessation IN Aneurysmal Subarachnoid Haemorrhage
DRAIN
1 other identifier
interventional
245
2 countries
4
Brief Summary
The DRAIN trial is an international multi-centre, 1:1 randomised, parallel-group, superiority clinical trial investigating gradual weaning vs. prompt closure of external ventricular drainage in patients with hydrocephalus following aSAH. The primary objective is to investigate the beneficial and harmful effects of gradual weaning versus prompt closure of EVD treatment in patients with aSAH.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2019
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 4, 2019
CompletedFirst Posted
Study publicly available on registry
May 13, 2019
CompletedStudy Start
First participant enrolled
June 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 18, 2024
CompletedJune 25, 2024
June 1, 2024
5 years
April 4, 2019
June 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VP-shunt implantation, all-cause mortality, or EVD-related infection.
The primary outcome is a composite outcome of VP-shunt implantation, all-cause mortality, and EVD-related infection.
6 months after ictus
Secondary Outcomes (2)
Number of serious adverse events (SAE) not including death
6 months after ictus
Health-related quality of life (EQ-5D-5L)
6 months after ictus
Other Outcomes (7)
Functional outcome according to modified Rankin Scale
6 months after ictus
The remaining dimensions of EQ-5D-5L
6 months after ictus
Fatigue Severity Scale (FSS)
6 months after ictus
- +4 more other outcomes
Study Arms (2)
Control intervention
ACTIVE COMPARATORPrompt closure, based on best available scientific data
Experimental intervention
EXPERIMENTALGradual weaning, based on best available scientific data
Interventions
Prompt closure of EVD with subsequent observation period
Gradual weaning of EVD with 5 cmH2O increase in drainage resistance daily until complete closure with subsequent observation period
Eligibility Criteria
You may qualify if:
- \>= 18 years of age
- Diagnosis of aneurysmal subarachnoid haemorrhage (aSAH)
- External ventricular drain (EVD) for \>= 6 days
- Drain output of =\< 220 mL on day of randomisation
- Drain resistance of 10 or 15 cm H2O
- Stable or improving Glasgow Coma Scale (GCS) \>= 9 during the last 24 hours
- Signed informed consent (from patient or next-of-kin)
You may not qualify if:
- None-tolerability of an increase of resistance to 10 cm H2O due to clinical deterioration or an increase in ICP
- Severe pre-existing (physical or mental) disability or severe co-morbidity that would lead to poor outcome even if the patient made a full recovery from the aSAH
- Life expectancy shorter than 48 hours after admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Department of Neurosurgery, Odense University Hospital
Odense, Region Syd, 5000, Denmark
Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet
Copenhagen, 2100, Denmark
Department of Neurosurgery, Oslo University Hospital
Oslo, Norway
Department of Neurosurgery, University Hospital of North Norway
Tromsø, Norway
Related Publications (2)
Capion T, Lilja-Cyron A, Juhler M, Moller K, Sorteberg A, Ronning PA, Poulsen FR, Wismann J, Schack AE, Ravlo C, Isaksen J, Lindschou J, Gluud C, Mathiesen T, Olsen MH. Prompt closure versus gradual weaning of external ventricular drain for hydrocephalus following aneurysmal subarachnoid haemorrhage: a statistical analysis plan for the DRAIN randomised clinical trial. Trials. 2024 Jul 15;25(1):479. doi: 10.1186/s13063-024-08305-4.
PMID: 39010208DERIVEDCapion T, Lilja-Cyron A, Olsen MH, Juhler M, Moller K, Sorteberg A, Ronning PA, Poulsen FR, Wismann J, Ravlo C, Isaksen J, Lindschou J, Gluud C, Mathiesen T. Prompt closure versus gradual weaning of external ventricular drainage for hydrocephalus following aneurysmal subarachnoid haemorrhage: Protocol for the DRAIN randomised clinical trial. Acta Anaesthesiol Scand. 2023 Sep;67(8):1121-1127. doi: 10.1111/aas.14263. Epub 2023 May 10.
PMID: 37165711DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tiit I Mathiesen, DMSc
Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the nature of the intervention with two arms with different time course it is not possible to mask patients nor investigators or care providers
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
April 4, 2019
First Posted
May 13, 2019
Study Start
June 6, 2019
Primary Completion
June 18, 2024
Study Completion
June 18, 2024
Last Updated
June 25, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share
Data wille be available upon reasonable request and only after approval from local authorities and involving parties.